Mkt Cap$2.13T-1.70%
24h Vol$113.62B
BTC Dom55.8%
ETH Dom8.8%
F&G12Extreme Fear
BTC$59,062.00-2.40% ETH$1,555.56-4.37% USDT$0.9985+0.00% BNB$551.13-2.15% USDC$0.9998+0.01% XRP$1.03-2.86% SOL$65.77-3.02% TRX$0.3227-1.67% FIGR_HELOC$1.03-0.57% HYPE$61.20+2.00% DOGE$0.0728-2.85% USDS$0.9996+0.04% RAIN$0.0158-0.65% LEO$9.34-1.60% ZEC$394.13-3.85% XLM$0.1775-4.23% BTC$59,062.00-2.40% ETH$1,555.56-4.37% USDT$0.9985+0.00% BNB$551.13-2.15% USDC$0.9998+0.01% XRP$1.03-2.86% SOL$65.77-3.02% TRX$0.3227-1.67% FIGR_HELOC$1.03-0.57% HYPE$61.20+2.00% DOGE$0.0728-2.85% USDS$0.9996+0.04% RAIN$0.0158-0.65% LEO$9.34-1.60% ZEC$394.13-3.85% XLM$0.1775-4.23%
News

market analysis

Total Stories
1,143
Section
market analysis
Novo Nordisk (NVO) Shares Fall on Unexpected 2026 Sales Outlook
Market Analysis

Novo Nordisk (NVO) Shares Fall on Unexpected 2026 Sales Outlook

Novo Nordisk shares tumbled 18% after the company issued unexpectedly weak 2026 guidance, forecasting sales could decline as much as 13%.

Tim FriesFeb 4, 20264 min read